157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)
- Resource Type
- Abstract
- Source
- In
Immuno-Oncology and Technology December 2023 20 Supplement - Subject
- Language
- ISSN
- 2590-0188